UniProt Q7B8V4
BoNT/A (Q7B8V4)
BoNT/A (UniProt Q7B8V4), EC 3.4.24.69: 27 experimental structures on GenesisL1, 1 ligand bound, 25 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q7B8V4
- Protein
- BoNT/A
- EC
- 3.4.24.69
- Experimental structures
- 27
- Predicted models
- 0
- Ligands
- 1
- Pockets
- 25 · 2 records with a druggable one
Structures
27 records of Q7B8V4 in the MolNFT archive: 27 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2ILP | Clostridium botulinum Serotype A Light Chain inhibited by 4-chlorocinnamic hydroxamate | x-ray diffraction | A, B | — | — |
| 2ILP | Clostridium botulinum serotype a light chain inhibited by 4- chlorocinnamic hydroxamate | x-ray diffraction | A, B | — | — |
| 2IMA | Clostridium botulinum Neurotoxin Serotype A Light Chain Inhibited by 2,4-dichlorocinnamic… | x-ray diffraction | A, B | — | — |
| 2IMA | Clostridium botulinum neurotoxin serotype a light chain inhibited by 2,4-dichlorocinnamic… | x-ray diffraction | A, B | — | — |
| 2IMB | Clostridium botulinum Neurotoxin Serotype A Light Chain Inhibited by L-arginine hydroxamate | x-ray diffraction | A, B | — | — |
| 2IMB | Clostridium botulinum neurotoxin serotype a light chain inhibited by L-arginine hydroxamate | x-ray diffraction | A, B | — | — |
| 2IMC | Clostridium botulinum Neurotoxin Serotype A Light Chain, Residues 1-424 | x-ray diffraction | A, B | — | — |
| 2IMC | Clostridium botulinum neurotoxin serotype a light chain, residues 1- 424 | x-ray diffraction | A, B | — | — |
| 2ISE | Botulinum Neurotoxin A Light Chain WT Crystal Form A | x-ray diffraction | A, B | — | — |
| 2ISE | Botulinum neurotoxin a light chain wt crystal form a | x-ray diffraction | A, B | — | — |
| 2ISG | Botulinum Neurotoxin A Light Chain WT Crystal Form B | x-ray diffraction | A, B | — | — |
| 2ISG | Botulinum neurotoxin a light chain wt crystal form B | x-ray diffraction | A, B | — | — |
| 2ISH | Botulinum Neurotoxin A Light Chain WT Crystal Form C | x-ray diffraction | A, B | — | — |
| 2ISH | Botulinum neurotoxin a light chain wt crystal form C | x-ray diffraction | A, B | — | — |
| 3NF3 | Crystal structure of BoNT/A LC with JTH-NB-7239 peptide | x-ray diffraction | A | — | — |
| 3NF3 | Crystal structure of BONT/A lc with jth-nb-7239 peptide | x-ray diffraction | A | — | — |
| 3V0A | 2.7 angstrom crystal structure of BoNT/Ai in complex with NTNHA | x-ray diffraction | A | — | — |
| 3V0A | 2.7 ångström crystal structure of BONT/AI in complex with ntnha | x-ray diffraction | A | — | — |
| 3V0B | 3.9 angstrom crystal structure of BoNT/Ai in complex with NTNHA | x-ray diffraction | A | — | — |
| 3V0B | 3.9 ångström crystal structure of BONT/AI in complex with ntnha | x-ray diffraction | A | — | — |
| 3V0C | 4.3 angstrom crystal structure of an inactive BoNT/A (E224Q/R363A/Y366F) | x-ray diffraction | A | — | — |
| 3V0C | 4.3 ångström crystal structure of an inactive BONT/A (E224Q/R363A/Y366F) | x-ray diffraction | A | — | — |
| 6UI1 | Crystal structure of BONT/A-lchn domain in complex with vhh cia-D12, cia-B5, and cia-H7 | x-ray diffraction | A | — | — |
| 6UL6 | Crystal Structure of BoNT/A-LCHn domain in complex with VNA ciA-D12/11/ciA-B5 and VHH ciA-H7 | x-ray diffraction | A | — | 13 (best 0.88) |
| 6UL6 | Crystal structure of BONT/A-lchn domain in complex with vna cia- D12/11/CIA-B5 and vhh cia-H7 | x-ray diffraction | A | — | — |
| 7L6V | Crystal structure of BoNT/A-LC-JPU-A5-JPU-C1-JPU-H7-JPU-D12-ciA-F12 | x-ray diffraction | A | ZN | 12 (best 0.85) |
| 7L6V | Crystal structure of BONT/A-lc-jpu-A5-jpu-C1-jpu-H7-jpu-D12-cia-F12 | x-ray diffraction | A | ZN | — |
Ligands
- ZN · Zinc ion · in 2 records
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.